-
Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging CohortBrodmann M, Keirse K, IN.PACT Global Study Investigators -
The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical OutcomesVerheye S, Vrolix M, Kumsars I et al.
-
Outcomes after drug-coated balloon treatment for patients with calcified coronary lesionsIto R, Ueno K, Yoshida T et al.
-
Contemporary use of drug-coated balloons in coronary artery disease: Where are we now?Picard F, Doucet S, Asgar AW
-
Therapeutic Options for In-Stent RestenosisNicolais C, Lakhter V, Chatterjee S et al.
-
Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting StentsSim HW, Ananthakrishna R, Loh JP et al.
-
Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent RestenosisTM Rhee, JM Lee, ES Shin et al.
-
Drug-Coated Balloon Versus Drug-Eluting Stent in Primary Percutaneous Coronary Intervention: A Feasibility StudyGobić D, Tomulić V, Lulić D et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
